Scintillation Proximity Assays in High-Throughput Screening
- 1 June 2008
- journal article
- review article
- Published by SAGE Publications in ASSAY and Drug Development Technologies
- Vol. 6 (3) , 433-455
Abstract
Scintillation proximity assays (SPAs) have become a powerful tool for high-throughput screening (HTS) because they can measure the activity and binding of very diverse classes of drug targets. By applying the basic principles of ligand–receptor binding and enzyme kinetics, it is possible to build a large variety of miniaturized, high-throughput assays and screen millions of compounds. SPAs are enabled by the diversity of radiolabeled molecules and affinity tags that are commercially available. These synthetic radiotracers allow for minimal disturbance of the natural binding interactions. This article will present a comprehensive review of the technique and provide detailed information on its applications related to HTS, highlighting the major uses and giving some suggestions for future research.Keywords
This publication has 121 references indexed in Scilit:
- Miniaturized Receptor Binding Assays: Complications Arising from Ligand DepletionSLAS Discovery, 2007
- Inhibition ofStenotrophomonas maltophiliadihydrofolate reductase by methotrexate: A single slow-binding processJournal of Enzyme Inhibition and Medicinal Chemistry, 2007
- The 7 TM G‐Protein‐Coupled Receptor Target FamilyChemMedChem, 2006
- A detergent-based assay for the detection of promiscuous inhibitorsNature Protocols, 2006
- Differential Requirements for Actin Polymerization, Calmodulin, and Ca2+Define Distinct Stages of Lysosome/Phagosome TargetingMolecular Biology of the Cell, 2006
- Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: Method validation and applicationJournal of Pharmaceutical and Biomedical Analysis, 2005
- WGA-Coated Yttrium Oxide Beads Enable an Imaging-Based Adenosine 2a Receptor Binding Scintillation Proximity Assay Suitable for High Throughput ScreeningASSAY and Drug Development Technologies, 2004
- A Widely Applicable, High-Throughput TR-FRET Assay for the Measurement of Kinase Autophosphorylation: VEGFR-2 as a PrototypeSLAS Discovery, 2003
- The Potential for CYP2D6 Inhibition Screening Using a Novel Scintillation Proximity Assay-Based ApproachSLAS Discovery, 2001
- A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization.Proceedings of the National Academy of Sciences, 1966